Iracema Leroi

Summary

Affiliation: Christie Hospital
Country: UK

Publications

  1. ncbi request reprint Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease
    Iracema Leroi
    Department of Psychiatry, North Manchester General Hospital, Manchester, UK
    Int J Geriatr Psychiatry 19:1-8. 2004
  2. doi request reprint A pilot randomized controlled trial of sleep therapy in Parkinson's disease: effect on patients and caregivers
    Iracema Leroi
    North Manchester General Hospital, Delaunays Rd, Manchester, UK
    Int J Geriatr Psychiatry 25:1073-9. 2010
  3. ncbi request reprint Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review
    Iracema Leroi
    Division of Psychiatry, University of Manchester, Manchester, United Kingdom
    J Neurol Sci 248:104-14. 2006
  4. ncbi request reprint The epidemiology of psychosis in dementia
    Iracema Leroi
    Neuropsychiatry Service, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD 21287, USA
    Am J Geriatr Psychiatry 11:83-91. 2003
  5. ncbi request reprint Cognitive impairment and psychiatric symptoms in 133 patients with diseases associated with cerebellar degeneration
    Christine M Liszewski
    Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Neuropsychiatry Clin Neurosci 16:109-12. 2004
  6. ncbi request reprint Amantadine for executive dysfunction syndrome in patients with dementia
    Shannon J Drayton
    Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Psychosomatics 45:205-9. 2004
  7. ncbi request reprint Cognitive impairments in cerebellar degeneration: a comparison with Huntington's disease
    Jason Brandt
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21287 7218, USA
    J Neuropsychiatry Clin Neurosci 16:176-84. 2004
  8. ncbi request reprint A comparison of small and large assisted living facilities for the diagnosis and care of dementia: the Maryland Assisted Living Study
    Iracema Leroi
    Manchester Mental Health and Social Care Trust, University of Manchester, Department of Psychiatry and Behavioural Sciences, Mancheter, UK
    Int J Geriatr Psychiatry 22:224-32. 2007

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease
    Iracema Leroi
    Department of Psychiatry, North Manchester General Hospital, Manchester, UK
    Int J Geriatr Psychiatry 19:1-8. 2004
    ..To evaluate the efficacy and safety of donepezil, an acetylcholinesterase inhibitor, as a treatment for cognitive impairment and dementia in patients with Parkinson' s disease (PD)...
  2. doi request reprint A pilot randomized controlled trial of sleep therapy in Parkinson's disease: effect on patients and caregivers
    Iracema Leroi
    North Manchester General Hospital, Delaunays Rd, Manchester, UK
    Int J Geriatr Psychiatry 25:1073-9. 2010
    ..By means of a controlled trial, to investigate the efficacy, tolerability and feasibility of a multi-component sleep therapy intervention versus basic sleep hygiene education in PD patients with sleep disturbances and their live-in carers...
  3. ncbi request reprint Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review
    Iracema Leroi
    Division of Psychiatry, University of Manchester, Manchester, United Kingdom
    J Neurol Sci 248:104-14. 2006
    ..To review the clinical management of cognitive impairment and dementia related to Parkinson's disease (PD), with emphasis on pharmacologic intervention strategies such as cholinesterase inhibitors...
  4. ncbi request reprint The epidemiology of psychosis in dementia
    Iracema Leroi
    Neuropsychiatry Service, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD 21287, USA
    Am J Geriatr Psychiatry 11:83-91. 2003
    ..Authors compared delusions, hallucinations, and misidentification delusions in Alzheimer disease (AD) and vascular dementia (VaD) patients...
  5. ncbi request reprint Cognitive impairment and psychiatric symptoms in 133 patients with diseases associated with cerebellar degeneration
    Christine M Liszewski
    Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Neuropsychiatry Clin Neurosci 16:109-12. 2004
    ..Psychopathology, including depression, personality change, cognitive impairment, anxiety, and psychosis was noted in 51% of 133 patients...
  6. ncbi request reprint Amantadine for executive dysfunction syndrome in patients with dementia
    Shannon J Drayton
    Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Psychosomatics 45:205-9. 2004
    ..Despite its limitations, this study offers preliminary data to support a controlled trial of amantadine in patients with executive dysfunction syndrome...
  7. ncbi request reprint Cognitive impairments in cerebellar degeneration: a comparison with Huntington's disease
    Jason Brandt
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21287 7218, USA
    J Neuropsychiatry Clin Neurosci 16:176-84. 2004
    ..These differences may reflect the involvement of the cerebellar dentate nucleus and the striatal nuclei in separate "loops" or closed circuits, linking them with specific areas of cerebral neocortex...
  8. ncbi request reprint A comparison of small and large assisted living facilities for the diagnosis and care of dementia: the Maryland Assisted Living Study
    Iracema Leroi
    Manchester Mental Health and Social Care Trust, University of Manchester, Department of Psychiatry and Behavioural Sciences, Mancheter, UK
    Int J Geriatr Psychiatry 22:224-32. 2007
    ..To compare the demographic, clinical, and psychiatric characteristics of residents living in small (< or = 15 beds) and large assisted living (AL) facilities in the United States...